Search by Drug Name or NDC

    NDC 41163-0630-26 equaline anti nausea 1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL Details

    equaline anti nausea 1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL

    equaline anti nausea is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Supervalu Inc. The primary component is DEXTROSE; FRUCTOSE; PHOSPHORIC ACID.

    Product Information

    NDC 41163-0630
    Product ID 41163-630_4e1bd9fe-3025-4125-9e3e-230d5b87c337
    Associated GPIs
    GCN Sequence Number 004698
    GCN Sequence Number Description phosphorated carbo(dext-fruct) SOLUTION ORAL
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 73710
    HICL Sequence Number 015060
    HICL Sequence Number Description PHOSPHORATED CARBOHYDRATE (DEXTROSE AND FRUCTOSE)
    Brand/Generic Generic
    Proprietary Name equaline anti nausea
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextrose (glucose), Levulose (fructose), Phosphoric Acid
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 1.87; 1.87; 21.5
    Active Ingredient Units g/5mL; g/5mL; mg/5mL
    Substance Name DEXTROSE; FRUCTOSE; PHOSPHORIC ACID
    Labeler Name Supervalu Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2023-12-31

    Package

    NDC 41163-0630-26 (41163063026)

    NDC Package Code 41163-630-26
    Billing NDC 41163063026
    Package 1 BOTTLE in 1 CARTON (41163-630-26) / 118 mL in 1 BOTTLE
    Marketing Start Date 2004-09-28
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f3b7efe0-8d3c-4fc2-b878-c20b962e6266 Details

    Revised: 10/2018